Results

Total Results: 80 records

Showing results for "anticoagulant prophylaxis".

61. Psi90 Factsheet Faq V2 (pdf file)
    qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ_v2.pdf
    October 05, 2016 - 12 events in this population may be less preventable due to safety concerns with pharmacological prophylaxis

62. Surveillance for Adverse Drug Events in Ambulatory Pediatrics (pdf file)
    digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
    January 01, 2011 - previous work we have shown that ambulatory ADEs related to high-alert medications – particularly anticoagulants … started during hospitalization may be continued without adequate outpatient monitoring (e.g., oral anticoagulants … definition: “an effect which is noxious and unintended, and which occurs at doses used in man for prophylaxis … hazardous medications that are used heavily in adults, but much less frequently in children – such as anticoagulants

63. National Web-Based Teleconference on Utilizing Health IT to Improve Medication Management for the Care of Elderly Patients (pdf file)
    digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
    August 18, 2011 - 100 120 Drug interactions Inadequate monitoring Failure to act on monitoring Known allergy No prophylaxis

64. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk … Aspirin for the Primary Prevention of Cardiovascular Events 24 Adults without known CVD Aspirin prophylaxis

65. Health Information Exchange Utilization and Inter-hospital Transfer Outcomes - Final Report (pdf file)
    digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
    January 01, 2023 - ; 95% CI, 0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis prophylaxis

66. Advances in Patient Safety | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/reports/advances/index.html
    July 01, 2022 - Bartholomew Clark, Bruce Houghton Implementation of an Evidence-based Protocol for Surgical Infection Prophylaxis

67. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - 34 recommend the use of low-dose aspirin for cardiovascular (including but not specific to stroke) prophylaxis

68. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … population-based, observational studies in which the uptake, continuation, and discontinuation of aspirin prophylaxis

69. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 15, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk

70. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
    April 01, 2016 - recommend the use of low-dose aspirin for cardiovas- cular (including but not specific to stroke) prophylaxis

71. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - Uncontrolled hypertension and concomitant use of anticoagulants also increase the risk for serious bleeding … Association, the American Heart Association further recommended the use of aspirin for cardiovascular prophylaxis

72. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
    March 01, 2007 - Aspirin chemo- prophylaxis of colorectal cancer was the focus of 8 case– control studies (17–24), 7 cohort … Antiplatelet agents and anticoagulants for hyperten- sion. … other major disease Exclusion criteria: Sensitivity to aspirin; aspirin use �1 time/wk; use of oral anticoagulants

73. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - bleeding risk either due to risk factors (smoking, uncontrolled hypertension) or co-medication with anticoagulants … Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

74. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … population-based, observational studies in which the uptake, continuation, and discon- tinuation of aspirin prophylaxis

75. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
    May 06, 2022 - bleeding risk either due to risk factors (smoking, un- controlled hypertension) or co-medication with anticoagulants … Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

76. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - Uncontrolled hypertension and concomitant use of anticoagulants also increase the risk for serious bleeding … Association, the American Heart Association further recommended the use of aspirin for cardiovascular prophylaxis

77. Mindfulness: Engaging Frontline Providers in Antimicrobial Stewardship (June 10, 2014) | Agency for Healthcare Research and Quality
    www.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

78. Paul Tedrick (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis

79. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

80. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
    April 01, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovas- cular